We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

Francis, who is currently CEO of gene therapy specialist Purespring Therapeutics and cardiovascular drug developer company Forcefield ... it had struggled to absorb Actavis, the former generics ...

By increasing the number of manufacturers Cuban's company works with, it can offer more drugs at lower cost, but there's no necessity for manufacturers to work with companies like MCCPDC.

After hours: January 31 at 5:30:46 PM EST Loading Chart for RIGL ...

Ishita Drugs & Industries Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 25.42 Crore) operating in Pharmaceuticals sector. Ishita Drugs & Industries Ltd. key ...

Kilitch Drugs(I) Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 502.01 Crore) operating in Pharmaceuticals sector. Kilitch Drugs(I) Ltd. key Products/Revenue ...

After hours: January 28 at 4:34:52 PM EST Loading Chart for RYTM ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so that physicians would prescribe a specific migraine drug to patients ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.